Felvizumab

Felvizumab
Humanized (from mouse)
Target	RSV
Clinical data
ATC code	none;
Identifiers
CAS Number	167747-20-8 ;
ChemSpider	none;
UNII	W9ZA2K5Q83;
KEGG	D04136 ;
	(what is this?) (verify)

Felvizumab is a

humanized monoclonal antibody against respiratory syncytial virus.^[1]^[2]

References

^ "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
ISBN 978-1-351-78989-9
.

Fungal
Human

Efungumab^†

Viral
Human

Ansuvimab

Atoltivimab (+maftivimab/odesivimab)

Avdoralimab^§

Bamlanivimab^† (+etesevimab)^†

Bebtelovimab^§

Casirivimab^† (+imdevimab
)

Cilgavimab^† (+tixagevimab
)^†

Diridavumab^§

Etesevimab
^†

Exbivirumab^§

Foravirumab^§

Imdevimab^† (+casirivimab
)

Libivirumab^§

Maftivimab

Nirsevimab^†

Odesivimab

Pemivibart

Rafivirumab^§

Regavirumab^§

Regdanvimab

Sevirumab^†

Sotrovimab

Suptavumab

Tixagevimab^† (+cilgavimab
)^†

Tuvirumab^§

Chimeric

Cosfroviximab

Larcaviximab

Porgaviximab

Vilobelimab^†

Humanized

Felvizumab^§

Lenvervimab^†

Motavizumab^†

Palivizumab

Suvizumab^§

Bacterial
Human

Nebacumab

Panobacumab^§

Raxibacumab

Mouse

Edobacomab^§

Chimeric

Pagibaximab^†

Humanized

Tefibazumab^†

Toxin
Human

Actoxumab^§

Bezlotoxumab

Suvratoxumab

Chimeric

Obiltoxaximab

Humanized

Urtoxazumab^§

^#WHO-EM

^‡Withdrawn from market

Clinical trials:
^†Phase III

^§Never to phase III

drug article is a stub. You can help Wikipedia by expanding it.
v
t
e

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.
v
t
e

[1] "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.

[2] ISBN 978-1-351-78989-9
.

[1]

[2]